Antiretroviral endorsement issue
Safety Classified by Officially
Technical issue affecting prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir
For individual prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir that are dispensed from 1 November 2026 to 1 December 2026, Pharmac asks pharmacists to annotate and process the prescription as ‘endorsed', even though the current endorsement is for PSO supply for PEP.
This will allow pharmacy claims to be processed.
Pharmac has identified a technical issue with the funding rule for emtricitabine with tenofovir disoproxil and dolutegravir that came into effect on 1 November 2026. The issue relates to the endorsement requirement associated with PSO supply for post-exposure prophylaxis (PEP).
The intent was for the endorsement requirement to apply only to PSO supply for PEP. However, the schedule system, cannot currently distinguish between PSO claims and individual prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir.
Pharmac intends to resolve the issue through the 1 December 2026 update to the Schedule.
Prescriber responsible for PEP use on PSO
When ordering on a PSO, the prescriber has the responsibility to ensure that the use is limited to PEP only and that at the time of supply the prescriber has obtained informed consent for the unregistered indication.
When supplying on PSO, pharmacists are not required to confirm the use is for PEP or to ensure informed consent has been obtained.
This is an extract. The publication continues at the source.
© Pharmac, licensed under CC BY 4.0. Licence
Read the original at the source: https://www.pharmac.govt.nz/news-and-resources/news/antiretroviral-endorsement-issue
Officially imported this from Pharmac’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Pharmac — imported from official source
- Official source
- https://www.pharmac.govt.nz/news-and-resources/news/rss RSS
- Imported
- November 09, 2026 03:31
- Versions
- 1 recorded
- Identity
-
https://www.pharmac.govt.nz/news-and-resources/news/antiretroviral-endorsement-issue